The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their ...
In a major relief for the Indian pharmaceutical industry, the U.S. administration has exempted pharmaceuticals from the ...
Generic medicines may cost higher in the US if Indian pharma companies decide to pass on the 26 per cent tariff in their ...
Indian drugmakers relieved as Trump exempts pharmaceuticals from tariffs, highlighting critical role of generic medicines in ...
Indian companies supply around 40% of all generic drugs used in the US; Pharmaceuticals remain untouched by US’ tariff ...
However, in his Wednesday speech, Trump indicated that tariffs on pharmaceutical imports may not be totally off the table.
New US tariffs on medical devices pose challenges to India's growing export market. AiMeD highlights potential impact on ...
Over the recent tariff announced by the US President, industry bodies in India have called the move a significant challenge ...
India's pharmaceutical sector benefits from the US excluding it from reciprocal tariffs, securing affordable medicines.
US imposed 26 per cent tariffs on Indian can possibly impact the Indian Medical Devices sector, said the Rajiv Nath, Forum Cordinator of AiMeD, however he pressed on the need to explore windows of ...
First, imposing a 26% tariff on medical devices imported from India will be a sharp escalation from previous tariffs.
The US Administration has exempted pharmaceuticals from reciprocal tariffs, highlighting the significance of affordable, life ...